Interestingly, we found no association between the production levels of TGF-β and TNF-α by lupus monocytes and disease activity (determined by SLEDAI), treatment, laboratory or clinical features, or demographic characteristics in the patients (Table 1 and data not shown). The gene discussed is TGFB1; the disease is systemic lupus erythematosus.